It looks like the more interesting part of this article is the accelerated process to move from early research to human trials. We have lots of ways of curing c

It looks like the more interesting part of this article is the accelerated process to move from early research to human trials. We have lots of ways of curing cancer in mice that never panned out in humans, but we have a better chance of finding solutions that work if we can remove some of the impediments to moving forward with trials. Faster progress is dependent on decreasing the time each iteration takes.